Express Scripts-Medco deal approved by U.S. regulators

Back to TopCommentsE-mailPrintBookmark and Share

Express Scripts Inc.’s $29.1 billion bid for rival drug benefit manager Medco Health Solutions Inc. won unconditional approval from U.S. antitrust regulators, clearing the way to create the biggest manager of prescription-drug benefits for corporate and government clients.

The FTC’s decision, the result of a three-to-one vote by the commissioners, enables St. Louis-based Express Scripts to complete the purchase of Medco of Franklin Lakes, N.J., that was announced on July 21.

The companies have about 800 employees in total in the Indianapolis area. It is unclear how local consolidation will affect local employment.

The FTC said in a prepared statement that an eight-month investigation of the proposed deal “revealed a competitive market for pharmacy benefit management services characterized by numerous, vigorous competitors who are expanding and winning business from traditional market leaders.”

FTC Commissioner Julie Brill, who dissented, said in a separate statement that the transaction is an industry “game changer” that creates a “merger to duopoly.” She called on the commission to take another look at the pharmacy benefits management market in three years.

George Paz, Express Scripts’s chairman and CEO, said in a statement, “Our merger is exactly what the country needs now. It represents the next chapter of our mission to lower costs, drive out waste in healthcare and improve patient health.”

Shares of Express Scripts gained 5 percent, to $56.91 each, in early trading Monday.

In July, Express Scripts agreed to pay $28.80 a share in cash plus 0.81 Express Scripts share for each Medco share held, the companies said at the time. Including net debt, the acquisition was valued at $34.3 billion, exceeding the $21.7 billion deal that formed CVS Caremark Corp. in 2007 as the biggest in the industry, according to data compiled by Bloomberg.

The companies, known as pharmacy-benefits managers, or PBMs, negotiate prices with drugmakers for health-plan sponsors, manage worker claims and track patients’ use of medicines. Their profits are tied to cutting their clients’ drug costs.

PBMs save health-plan sponsors and consumers as much as $87 billion in annual prescription-drug costs, Compass Lexecon, an economic consulting firm in Washington, D.C., said in a December report funded by Express Scripts and Medco.

A combined Express-Medco would handle 34 percent of prescriptions in the U.S. this year, said Adam Fein, founder and president of Pembroke Consulting Inc. in Philadelphia, who is a consultant for Express Scripts.

That share will shrink to 29 percent next year because UnitedHealth Group Inc. of Minnetonka, Minnesota, the biggest U.S. health plan by sales, switched from Medco to its own pharmacy benefits unit, OptumRx, Fein said.

About 31 percent of specialty drugs -- medicines for ailments such as cancer and HIV that are injected or infused or require special handling -- sold in the U.S. in 2010 passed through pharmacies owned by Express Scripts or Medco, according to Fein.

Scrutiny of the industry is part of the Obama administration’s effort to rein in health-care costs, said Art Lerner, former assistant director for health in the FTC’s Bureau of Competition.

“They view competition and enforcement of the antitrust laws as an important element in trying to make sure health care” is high quality and inexpensive, said Lerner, a Washington-based partner at Crowell & Moring LLP.

In her dissent, Brill said the merger will create “a highly concentrated market” for pharmacy benefit management services and argued that the FTC should have sought an injunction to block the deal.

“The legal presumption against this merger is overwhelming and is not, in my view, sufficiently rebutted by evidence regarding competitive effects or entry,” Brill said.

The majority of commissioners said the merging companies aren’t “particularly close competitors, the market today is not conducive to coordinated interaction, and there is little risk of the merged company exercising monopsony power,” where a large buyer controls the market and drive down prices.

Express Scripts and Medco have told regulators the merged company would help reduce U.S. medical costs, a goal of the 2010 health-care law, in part by extracting lower prices from drugmakers and tracking whether patients take their medicines.

The proposed acquisition drew opposition from drugstore chains and pharmacists, who have said Express Scripts and its competitors have done little to slow drug-price increases.

The National Association of Chain Drug Stores, the National Community Pharmacists Association and independent pharmacies filed a lawsuit March 29 seeking to block the merger in federal court in Pittsburgh, claiming the purchase of Medco by Express Scripts would violate antitrust laws by shrinking competition and raising consumer prices.

“The undisputed fact is that supermarket pharmacies are able to provide lower cost drugs to patients” than pharmacy benefit managers, wrote Cathy Polley, a vice president at the Food Marketing Institute, and Erik Lieberman, the group’s regulatory counsel, in a Feb. 2 letter to FTC Chairman Jon Leibowitz.

The Arlington, Va.-based trade group represents U.S. companies that operate more than 25,000 food stores and almost 22,000 pharmacies that generate $650 billion in revenue annually.

Pharmacists said that Express Scripts-Medco will have an incentive to divert patients from drug stores to the company’s mail-order business.

At a Dec. 6 hearing of the Senate Judiciary antitrust subcommittee, Express Scripts’ George Paz said the company would use its increased size after the acquisition to bargain for better prices from drugmakers and pharmacies.

Express Scripts should ensure “that cost savings will be passed down to customers and just won’t result in higher profits,” said Sen. Al Franken, a Minnesota Democrat.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. The Walgreens did not get a lot of traffic. It was not located on the corner of the intersection, and not really visible from Emerson. Meanwhile the CVS there is huge and right on the corner. I am guessing a lot of people drove by a million times and never knew the Walgreens was there. Although, with the new Walmart market going in, that area could really see a lot of increase in traffic soon.

  2. You folks don't have a clue. There is a legal way to enter this country and to get aid. This left unchecked could run us to ruin quickly. I also heard that 'supporters' were getting major $$ to take them in? Who's monitoring this and guess who pays the bill? I support charitable organizations... but this is NOT the way to do it!

  3. Apparently at some time before alcohol has been served at the fair. The problem is that beer or wine used to be a common drink for people before soft drinks and was not thought to be that unusual. Since many folks now only drink to see how much they can drink or what kind of condition they can end up in it becomes more problematic. Go to Europe and its no big deal just as if you had sodas of milk to drink everyday. Its using common sense that is lacking now days.

  4. To address the epic failure of attracting race fans to both the Indy 500 and Brickyard 400 would take too much of my time to write. Bottom line Boles is clueless and obviously totally out of touch with the real paying fan base. I see nothing but death spin coming for the Brickyard, just like Indy. Get somebody in a place of power that understands what race fans want.

  5. I am a race fan through & through. It doesn't matter if it's Indy cars or Nascar. I love a great race. I go to several other tracks each year and you can see the entire track. I know Indy has tradition, but fans want to see the entire race. I sit in the Penthouse, am almost 60 years old, and would like to see a better TV screen in turn 1 so you can see the entire race. Then I think Indy needs to install an escalator so us old folks can make it up to the Penthouse and down again if we want more options to purchase food and drinks. Just a race fans opinion. Lights won't make the race any better, but you might be able to see the TV better at night. Turn 1's screen needs replaced with a better and bigger screen.